Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Neuropsychopharmacology

• Publication date

  1998-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0924-977X(97)00055-2PMID 9716307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

  2005cited by this paper
• Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats

  2005cited by this paper
• Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents

  2005cited by this paper
• A comparison of trazodone and fluoxetine: implications for a serotonergic mechanis of antidepressant action

  2005cited by this paper
• Ethical principles and guidelines for experiments on animals

  2005cited by this paper
• Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

  2004cited by this paper
• 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats.

  1996cited by this paper
• Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors.

  1996cited by this paper
• Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder

  1996cited by this paper
• Role of 5-HT in stress, anxiety, and depression.

  1996cited by this paper
• Differential activation of ZIF268 in the amygdala in response to mCPP

  1996cited by this paper
• Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor

  1996cited by this paper
• How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.

  1996cited by this paper
• m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor.

  1996cited by this paper
• Do the antidepressants have anxiogenic action

  1996cited by this paper
• Effect of d-fenfluramine on human experimental anxiety

  1996cited by this paper
• Daily administration ofm-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects

  1996cited by this paper
• Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation

  1996cited by this paper
• Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors.

  1996cited by this paper
• S-17-5 5HT2C receptor agonists and antagonists in animal models of anxiety

  1995cited by this paper
• Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors

  1995cited by this paper
• Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety

  1995cited by this paper
• Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

  1995cited by this paper
• 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects ofm-chlorophenylpiperazine

  1995cited by this paper
• Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area

  1995cited by this paper
• Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

  1995cited by this paper
• S-1-2 The relevance of behavioral probes in obsessive-compulsive disorder

  1995cited by this paper
• S-9-3 SSRIs in panic disorder

  1995cited by this paper
• Panicogenic effect of sumatriptan: A pilot study

  1995cited by this paper
• Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

  1994cited by this paper
• Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.

  1994cited by this paper
• Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.

  1994cited by this paper
• Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure.

  1994cited by this paper
• In vivo properties of SB 200646A, a 5‐HT2C/2B receptor antagonist

  1994cited by this paper
• New Findings in the Treatment of Panic Disorder

  1993cited by this paper
• Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.

  1993cited by this paper
• Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

  1993cited by this paper
• 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.

  1993cited by this paper
• N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

  1993cited by this paper
• Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.

  1993cited by this paper
• A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.

  1992cited by this paper
• Panic Attacks

  1992cited by this paper
• Does it matter which serotonin receptor is doing what?

  1991cited by this paper
• 5-HT and mechanisms of defence

  1991cited by this paper
• Electrostatics and computational modelling Editorial overview

  1991cited by this paper
• Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.

  1991cited by this paper
• Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam.

  1991cited by this paper
• Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.

  1990cited by this paper
• The effect of antidepressants on aversive periaqueductal gray stimulation in rats.

  1990cited by this paper
• Effects of daily oral m-chlorophenylpiperazine in elderly depressed patients. Initial experience with a serotonin agonist.

  1990cited by this paper
• The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution.

  1990cited by this paper
• 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.

  1989cited by this paper
• Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.

  1989cited by this paper
• 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

  1989cited by this paper
• Animal models for anxiety and response to serotonergic drugs.

  1989cited by this paper
• Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.

  1988cited by this paper
• Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: A double-blind comparative study with fluvoxamine and maprotiline.

  1988cited by this paper
• Serotonin function in anxiety

  1987cited by this paper
• Drug-induced penile erections in rats: indications of serotonin1B receptor mediation.

  1987cited by this paper
• Benzodiazepine Receptors and their Ligands

  1986cited by this paper
• Membrane-bound choline acetyltransferase in Torpedo electric organ: a marker for synaptosomal plasma membranes?

  1985cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Escape and approach induced by brain stimulation: a parametric analysis.

  1981cited by this paper
• Sensations evoked by stimulation in the midbrain of man.

  1969cited by this paper
• Learning motivated by electrical stimulation of the brain.

  1954cited by this paper

• Frequency–dependency of the involvement of dopamine D1/D5 and beta‐adrenergic receptors in hippocampal LTD triggered by locus coeruleus stimulation

  2022cites this paper
• 5-HT Receptors and the Development of New Antidepressants

  2021cites this paper
• New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties

  2020cites this paper
• 5-HT2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression

  2019cites this paper
• Serotonergic treatment normalizes midbrain dopaminergic neuron increase after periaqueductal gray stimulation

  2019cites this paper
• Serotonin receptors in depression and anxiety: Insights from animal studies

  2018cites this paper
• The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders

  2016cites this paper
• Tests for Anxiolytic Activity

  2015cites this paper
• The Role of Agomelatine in the Treatment of Anxiety Disorders

  2014cites this paper
• 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

  2013cites this paper
• B-1 Cell Immunoglobulin Directed Against Oxidation-Specific Epitopes

  2013cites this paper
• Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice

  2011cites this paper
• Abnormal Cerebral Benzodiazepine Receptors Binding Measured with [$^{123}I$]-Iomazenil SPECT in Panic Disorder

  2010cites this paper
• Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.

  2010cites this paper
• Social isolation stress induces ATF‐7 phosphorylation and impairs silencing of the 5‐HT 5B receptor gene

  2010cites this paper
• The periaqueductal gray and defensive behaviour : new clues from an old concept

  2009cites this paper
• Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray

  2008cites this paper
• S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

  2008cites this paper
• Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety.

  2008cites this paper
• 5-HT2C ligands: recent progress.

  2008cites this paper
• Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.

  2007cites this paper
• Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.

  2007cites this paper
• Citalopram Combined with Behavioral Therapy Reduces Cocaine Use: A Double-Blind, Placebo-Controlled Trial

  2007cites this paper
• Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.

  2006cites this paper
• Animal Models of Anxiety

  2006cites this paper
• A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants.

  2006cites this paper
• 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats

  2006cites this paper
• Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice.

  2006cites this paper
• Recent developments in anxiety disorders.

  2006cites this paper
• 5‐HT2 receptors and anxiety

  2005cites this paper
• Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray

  2005cites this paper
• Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice.

  2005cites this paper
• Innovative approaches for the development of antidepressant drugs: Current and future strategies

  2005cites this paper
• COX-2 Inhibitors

  2004cites this paper
• 5-HT2C receptor agonists as potential drugs for the treatment of obesity.

  2003cites this paper
• Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety.

  2003cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety.

  2002cites this paper
• Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.

  2002cites this paper
• Chapter 3: 5-HT2c receptor modulators: Progress in development of new CNS medicines

  2002cites this paper
• Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: Differential effects of fluoxetine and chlordiazepoxide

  2002cites this paper
• Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols

  2002cites this paper
• Acute effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked unconditioned defensive behaviours of the rat

  2002cites this paper
• Biological basis of anxiety and strategies for pharmacological innovation

  2002cites this paper
• 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze

  2002cites this paper
• Modeling panic attacks.

  2001cites this paper
• Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic.

  2001cites this paper
• Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695: A Comparison to Other Classes of Anxiolytic Agent

  2001cites this paper
• Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.

  2001cites this paper
• EFFICIENT SYNTHESIS OF THE 5-HT2C RECEPTOR AGONIST, ORG 37684

  2001cites this paper
• Utilisation d'un agoniste du récepteur 5-HT2C pour traiter les bouffées de chaleur

  2001cites this paper
• Chemistry and pharmacology of novel antidepressants

  2001cites this paper
• Brain 5-HT2Creceptors: potential role in anxiety disorders

  2000cites this paper
• Panic Disorder-A Malfunction of Multiple Transmitter Control Systems within the Midbrain Periaqueductal Gray Matter?

  2000cites this paper
• Serotonergic drugs in the treatment of depressive and anxiety disorders

  2000cites this paper
• Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

  2000cites this paper
• d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine

  2000cites this paper
• Measurement of Anxiety in Transgenic Mice

  2000cites this paper
• Posthallucinogen-Like Visual Illusions (Palinopsia) with Risperidone in a Patient without Previous Hallucinogen Exposure: Possible Relation to Serotonin 5HT2a Receptor Blockade

  2000cites this paper
• Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement.

  2000cites this paper
• 5-Hydroxytryptamine Receptors Mediating Carotid and Systemic Haemodynamic Effects: The Relation to Acute Antimigraine Therapy

  1999cites this paper
• The 5-HTlA receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats

  1999cites this paper
• The role of 5-HT2C receptors in affective disorders.

  1998cites this paper
• Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay.

  1998cites this paper
• 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.

  1998cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper
• Reciprocal Autoreceptor and Heteroreceptor Control of Serotonergic, Dopaminergic and Noradrenergic on Behalf Of: British Association for Psychopharmacology

  year unknowncites this paper